retatrutide thyroid cancer Implications of GLP-1 Receptor Agonist on Function: A Literature Review of Its Effects on Thyroid Volume, Risk of Cancer, Functionality and TSH Levels Retatrutide Side Effects: What Patients
Description
Confirm appropriate documentation of approved indications
Community-dose users (2-4 mg/week) are well below this
5,10 Lixisenatide (Adlyxin) is a GLP-1RA derived from exendin-4
Still, clinical trials are already exploring what doses work best for weight loss with the fewest side effects and how different doses are introduced and increased over time, which gives us helpful clues about how it may eventually be taken
Retatrutide vs Tirzepatide (Mounjaro): 28.7% vs 20.9% (2026 Data) Phase 3 trial comparison: Retatrutide 28.7% weight loss vs Tirzepatide 20.9%
Source List 1
